dual glp 1 glucagon receptor agonists Understanding the Difference: While both peptides are powerful metabolic tools, their pharmacology is distinct: • Tirzepatide (Manjaro): This is a agonist targeting GLP-1 (Glucagon-like peptide-1) and GIP (Glucose-dependent insulinotropic The clinically most relevant mechanisms
Pay in 4 interest-free payments of $6.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19






















![Dark Pupitar (41/109) (Stamped) [EX: Team Rocket Returns] Kale](https://cdn.shopify.com/s/files/1/0745/9002/8087/products/341192e3-6504-518f-928f-e8c02230c69b_68db390a-836d-4f64-b7a7-4d695c68b4a4.jpg?v=1696310653)

![Dark Tyranitar (19/109) (Stamped) [EX: Team Rocket Returns] 64](https://cdn.shopify.com/s/files/1/0745/9002/8087/products/0d2327f3-9343-5be0-a13e-4e9850ec4f49_709769cf-1530-41ab-9502-76e5bd0ede33.jpg?v=1696310653)

